General Anesthesia Practice Questions

Q: Which of the following statements regarding halothane is true?

Reduces arterial pressure. **Explanation:** Halothane is a potent volatile anesthetic agent that primarily causes a dose-dependent reduction in arterial blood pressure. **1. Why Option A is Correct:** Halothane reduces arterial pressure through two main mechanisms: **direct myocardial depression** (negative inotropy) and a reduction in cardiac output. Unlike other volatile agents (like isoflurane), it causes minimal peripheral vasodilation, meaning the drop in blood pressure is almost entirely due to its effect on the heart muscle itself. **2. Why the other options are incorrect:** * **Option B (Increases heart rate):** Halothane actually tends to cause **bradycardia** or maintain a normal heart rate. It blunts the baroreceptor reflex, meaning the body does not mount a compensatory tachycardia in response to the falling blood pressure. * **Option C (Decreases cardiac output):** While halothane *does* decrease cardiac output, the question asks for the most definitive clinical effect. In many standardized exams, "reduction in arterial pressure" is considered the hallmark hemodynamic effect of halothane. (Note: In some contexts, C is also physiologically true, but A is the primary clinical manifestation). * **Option D (Increases sympathoadrenal activity):** Halothane **depresses** the sympathetic nervous system. It does not cause the "sympathetic surge" seen with agents like desflurane. **High-Yield NEET-PG Pearls for Halothane:** * **Catecholamine Sensitization:** Halothane sensitizes the myocardium to epinephrine, increasing the risk of **ventricular arrhythmias** if exogenous adrenaline is used. * **Hepatotoxicity:** Associated with "Halothane Hepatitis" (Type II is immune-mediated and severe). * **Uterine Relaxation:** It is a potent uterine relaxant, making it useful for version but risky for postpartum hemorrhage. * **Sweet Odor:** It is non-pungent, making it the classic agent for **smooth inhalation induction** in pediatric patients.

Q: All of the following are features of Verrill's sign except?

Tingling sensation. **Verrill’s sign** is a clinical endpoint used primarily in intravenous sedation (conscious sedation), most commonly associated with the administration of benzodiazepines like **Diazepam** or **Midazolam**. It serves as a reliable indicator that the patient has reached an adequate level of sedation for dental or minor surgical procedures without progressing into deep anesthesia or respiratory depression. ### **Explanation of Options:** * **Correct Answer: B (Tingling sensation):** Tingling (paresthesia) is not a component of Verrill’s sign. While some patients may experience subjective sensations during drug induction, it is not a clinical marker of the sedation endpoint. * **Option A (Partial ptosis):** This is the **hallmark** of Verrill’s sign. It is defined as the drooping of the upper eyelid such that it covers approximately **half of the pupil**. * **Option C & D (Blurring vision & Slurring speech):** These are associated signs of central nervous system depression. As the patient approaches the Verrill’s sign endpoint, they typically experience diplopia (double vision), blurred vision, and a noticeable slowing or slurring of speech. ### **Clinical Pearls for NEET-PG:** 1. **The "50% Rule":** Verrill’s sign is specifically the **50% ptosis** of the eyelid. If ptosis exceeds this or the patient loses the lash reflex, they are entering a deeper stage of anesthesia than intended for conscious sedation. 2. **Guedel’s Chart vs. Verrill’s:** While Guedel’s stages describe ether anesthesia, Verrill’s sign is the specific gold standard for **IV Diazepam sedation**. 3. **Safety Margin:** Reaching Verrill’s sign indicates that the patient is relaxed and amnesic but can still maintain a patent airway and respond to verbal commands. 4. **O'Beirne's Sign:** Do not confuse Verrill's with O'Beirne's sign (related to the rectum/defecation) or Guedel's signs (stages of GA).

Q: What is the inducing agent of choice in DIC?

Ketamine. **Explanation:** The correct answer is **Ketamine**. In patients with **Disseminated Intravascular Coagulation (DIC)**, the primary clinical concern during induction is hemodynamic instability and severe hypotension, often resulting from underlying sepsis, trauma, or obstetric emergencies. **Why Ketamine is the choice:** Ketamine is a phencyclidine derivative that acts as a potent sympathomimetic. It stimulates the release of endogenous catecholamines, leading to an increase in heart rate, blood pressure, and cardiac output. This "pressor effect" makes it the induction agent of choice in hemodynamically unstable patients (shock) or those with active bleeding, which are common precursors to DIC. **Analysis of Incorrect Options:** * **Thiopentone:** A barbiturate that causes significant peripheral vasodilation and direct myocardial depression. In a patient with DIC/shock, this can lead to a catastrophic drop in blood pressure. * **Propofol:** Similar to Thiopentone, Propofol causes marked vasodilation and decreases systemic vascular resistance (SVR). It is contraindicated in patients who are hemodynamically compromised. * **Methohexitone:** Another barbiturate that, like Thiopentone, causes cardiovascular depression and is generally avoided in unstable patients. **High-Yield Clinical Pearls for NEET-PG:** * **Agent of choice for Shock/Hypovolemia:** Ketamine. * **Agent of choice for Bronchial Asthma:** Ketamine (due to bronchodilatory properties). * **Agent of choice for Day-care Surgery:** Propofol (due to rapid recovery and anti-emetic properties). * **Agent of choice for Neurosurgery/Increased ICT:** Thiopentone (decreases Cerebral Metabolic Rate and ICP). * **Contraindication for Ketamine:** Patients with Hypertension, IHD, or increased Intraocular/Intracranial pressure.

Q: The severe bronchospasm associated with rapacuronium is caused by which mechanism?

Unopposed action of M3 muscarinic receptors in the bronchus. **Explanation:** Rapacuronium, a non-depolarizing neuromuscular blocking agent (NMBA), was withdrawn from the market primarily due to its association with severe, life-threatening bronchospasm. **Mechanism of the Correct Answer:** The bronchospasm is mediated by the drug’s selective **antagonism of M2 muscarinic receptors** located on the pre-junctional parasympathetic nerve endings in the lungs. Normally, these M2 receptors act as an "off-switch" (negative feedback), inhibiting the further release of acetylcholine (ACh). By blocking these M2 receptors, rapacuronium causes an excessive, unregulated release of ACh. This excess ACh then acts on the **M3 muscarinic receptors** on the bronchial smooth muscle, leading to profound bronchoconstriction. Thus, the bronchospasm is due to the **unopposed action of M3 receptors.** **Analysis of Incorrect Options:** * **Option A & B:** While many NMBAs (like atracurium or mivacurium) cause bronchospasm via IgE-mediated allergy or direct histamine release from mast cells, rapacuronium-induced bronchospasm is unique because it occurs via a **non-histaminergic, muscarinic mechanism.** * **Option D:** Rapacuronium **blocks** (antagonizes) M2 receptors rather than activating them. Activation of M2 receptors would actually decrease ACh release and prevent bronchospasm. **High-Yield Clinical Pearls for NEET-PG:** * **Rapacuronium:** A rapid-onset, short-acting steroid NMBA (similar to rocuronium) that was withdrawn in 2001. * **M2 vs. M3:** Remember, **M2 is Pre-junctional** (Inhibitory) and **M3 is Post-junctional** (Excitatory/Bronchoconstriction). * **Drug of Choice for Bronchospasm in Anesthesia:** Ketamine (due to its sympathomimetic bronchodilatory effects) or Sevoflurane. * **Safest NMBA in Asthma:** Vecuronium or Cisatracurium (minimal histamine release).

Q: What is the muscle relaxant of choice in patients with renal and hepatic failure?

Cis–atracurium. **Explanation** The muscle relaxant of choice in patients with renal and hepatic failure is **Cis-atracurium**. **Why Cis-atracurium is the Correct Choice:** Cis-atracurium (an isomer of atracurium) is unique because it undergoes **Hofmann elimination**—a spontaneous, non-enzymatic degradation in the plasma that is dependent only on physiological pH and temperature. Because its metabolism and excretion do not rely on the kidneys or the liver, its duration of action remains predictable even in end-organ failure. Unlike its parent compound atracurium, cis-atracurium is more potent and produces significantly less **laudanosine** (a metabolite that can cause seizures) and triggers minimal histamine release. **Analysis of Incorrect Options:** * **Vecuronium:** It is primarily excreted via the bile (40-70%) and the kidneys (20-30%). In renal or hepatic failure, its duration of action is significantly prolonged due to decreased clearance and the accumulation of active metabolites (3-desacetyl vecuronium). * **Rocuronium:** It is mainly eliminated unchanged by the liver (up to 70%) and excreted in bile. While it is often used in rapid sequence induction, its half-life is significantly increased in patients with liver cirrhosis or renal impairment. * **Rapacuronium:** This was a rapid-onset agent but was withdrawn from the market worldwide due to a high incidence of severe bronchospasm. **High-Yield Clinical Pearls for NEET-PG:** * **Hofmann Elimination:** Remember the mnemonic "pH and Temp"—it occurs faster in alkalosis and hyperthermia, and slower in acidosis and hypothermia. * **Drug of Choice for Liver/Renal Failure:** Cis-atracurium. * **Drug of Choice for Day Care Surgery:** Mivacurium (shortest acting non-depolarizing agent, though metabolized by pseudocholinesterase). * **Laudanosine Toxicity:** Atracurium > Cis-atracurium. It is a CNS stimulant that can lower the seizure threshold.

Q: Which anesthetic agent predisposes to the maximum number of arrhythmias?

Halothane. ### Explanation **Correct Answer: C. Halothane** **Why Halothane is the Correct Answer:** Halothane is notorious for its **arrhythmogenic potential** due to its unique interaction with the myocardium. The primary mechanism is the **sensitization of the myocardium to endogenous and exogenous catecholamines** (epinephrine). This sensitization lowers the threshold for arrhythmias, making the heart highly susceptible to premature ventricular contractions (PVCs), ventricular tachycardia, and even fibrillation, especially in the presence of hypercarbia or surgical stress. Among all potent inhalational agents, Halothane carries the highest risk of these cardiac disturbances. **Analysis of Incorrect Options:** * **A. Isoflurane:** While it can cause tachycardia due to peripheral vasodilation (reflex tachycardia), it does not sensitize the heart to catecholamines to the extent Halothane does. It is generally considered "heart-stable." * **B. Enflurane:** Enflurane has a lower potential for arrhythmias than Halothane. Its primary clinical concern is its potential to lower the seizure threshold (epileptogenic), particularly during hypocapnia. * **C. Ether:** Diethyl ether maintains heart rate and blood pressure well due to sympathetic stimulation, but it is not associated with the specific catecholamine-sensitization seen with Halothane. **High-Yield Clinical Pearls for NEET-PG:** * **The "Halothane Shake":** Post-operative shivering is common with Halothane. * **Halothane Hepatitis:** A rare but severe immune-mediated hepatotoxicity (Type II). * **Safe Limit:** When using epinephrine locally with Halothane, the dose should be restricted to **1 µg/kg** to avoid arrhythmias. * **Agent of Choice for Induction:** While Halothane was historically used for pediatric inhalation induction due to its non-pungent odor, **Sevoflurane** has largely replaced it in modern practice.

Question 1

Which of the following statements regarding halothane is true?

Accepted Answer

Reduces arterial pressure

Answer

Increases heart rate

Answer

Decreases cardiac output

Answer

Increases sympathoadrenal activity

Question 2

A child presents with bladder exstrophy and chronic renal failure. What is the muscle relaxant of choice to be used during the surgery for exstrophy in this child?

Accepted Answer

Atracurium

Answer

Mivacurium

Answer

Pancuronium

Answer

Rocuronium

Question 3

The plane of surgical anesthesia during ether anesthesia is defined as?

Accepted Answer

From onset of regular respiration to cessation of spontaneous breathing

Answer

Loss of consciousness

Answer

Loss of consciousness to the onset of spontaneous respiration

Answer

Absence of reflexes

Question 4

All of the following are features of Verrill's sign except?

Accepted Answer

Tingling sensation

Answer

Partial ptosis

Answer

Blurring vision

Answer

Slurring speech

Question 5

What is the inducing agent of choice in DIC?

Accepted Answer

Ketamine

Answer

Thiopentone

Answer

Methohexitone

Answer

Propofol

Question 6

The severe bronchospasm associated with rapacuronium is caused by which mechanism?

Accepted Answer

Unopposed action of M3 muscarinic receptors in the bronchus

Answer

Allergic reaction

Answer

Massive histamine release

Answer

M2 muscarinic receptor activation

Question 7

In patients with liver disease, what is the preferred anesthetic agent?

Accepted Answer

Isoflurane

Answer

Halothane

Answer

Ether

Answer

None of the above

Question 8

What is the muscle relaxant of choice in patients with renal and hepatic failure?

Accepted Answer

Cis–atracurium

Answer

Vecuronium

Answer

Rocuronium

Answer

Rapacuronium

Question 9

Which anesthetic agent predisposes to the maximum number of arrhythmias?

Accepted Answer

Halothane

Answer

Isoflurane

Answer

Enflurane

Answer

Ether

Question 10

The use of succinylcholine is not contraindicated in which of the following conditions?

Accepted Answer

Cerebral stroke

Answer

Tetanus

Answer

Closed head injury

Answer

Hepatic failure

General Anesthesia — MCQs

General Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?